Table 1.
Descriptive statistics of the participants. Data reported as mean (standard deviation).
| Group | CBT-I | AC | BE | p-value |
|---|---|---|---|---|
| Sex | 9 Females | 8 Females | 10 Females | 0.33 |
| 1 Male | 2 Males | 0 Males | ||
| Race | 9 White | 9 White | 10 White | 0.58 |
| 0 Black | 0 Black | 0 Black | ||
| 1 Unknown | 1 Unknown | |||
| Ethnicity | 9 Non-Hispanic | 9 Non-Hispanic | 10 No’-Hispanic | 0.58 |
| 0 Hispanic | 0 Hispanic | 0 Hispanic | ||
| 1 Unknown | 1 Unknown | |||
| MS Type | 8 RR | 10 RR | 9 RR | 0.33 |
| 2 SP | 0 SP | 1 SP | ||
| Age (years) | 51.1 (7.9) | 50.4 (12.4) | 56.9 (10.1) | 0.32 |
| PDDS | 1.3 (2.21) | 1.7 (2.3) | 2.0 (2.1) | 0.77 |
| Disease Duration (Years) | 17.3 (8.5) | 9.1 (8.9) | 18.3 (11.4) | 0.09 |
| Medications | 7.0 (4.8) | 5.0 (3.8) | 8.2 (5.5) | 0.244 |
| Range 0–16 | Range 0–13 | Range 0–19 | ||
| Classification (n)* | ||||
| Disease-modifying | 5 | 6 | 7 | |
| Spasticity | 4 | 3 | 5 | |
| Pain | 4 | 1 | 2 | |
| Depression or Anxiety | 4 | 2 | 3 | |
| Vitamin | 4 | 1 | 8 | |
| Stimulant | 0 | 1 | 0 | |
| Bladder activity | 2 | 1 | 2 | |
| Sleep aid | 2 | 0 | 2 | |
| Cardiac related | 5 | 4 | 4 | |
| Asthma | 1 | 1 | 0 | |
| Diabetes | 1 | 0 | 0 | |
| Allergy | 4 | 3 | 2 | |
| Other | 6 | 9 | 6 | |
| None | 1 | 1 | 0 |
RR: Relapsing Remitting, SP: Secondary Progressive, PDDS: Patient Determined Disease Steps.
*
Number of individuals taking a medication within the listed classification. Individuals may be taking more than one medication within the classification.